Identification, Synthesis, and Activity of Novel Blockers of the Voltage-Gated Potassium Channel Kv1.5
Author:
Affiliation:
1. Aventis Pharma Deutschland GmbH, Medicinal Chemistry and DG Cardiovascular, D-65926 Frankfurt/Main, Germany
Publisher
American Chemical Society (ACS)
Subject
Drug Discovery,Molecular Medicine
Link
https://pubs.acs.org/doi/pdf/10.1021/jm0210461
Reference37 articles.
1. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates 11Reprints are not available.
2. IKs channel blockers: Potential antiarrhythmic agents
3. A safer leap into this dangerous world
4. Recent advances in arrhythmia therapy: treatment and prevention of atrial fibrillation
Cited by 59 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Advancements in gene therapy approaches for atrial fibrillation: Targeted delivery, mechanistic insights and future prospects;Current Problems in Cardiology;2024-04
2. Сardioprotective agents with biaromatic structure. Part 5. Potassium Kv1.5-channels blockers;Pharmacokinetics and Pharmacodynamics;2023-07-18
3. Multitargeting in cardioprotection: An example of biaromatic compounds;Archiv der Pharmazie;2023-06-22
4. Genome Editing and Atrial Fibrillation;Advances in Experimental Medicine and Biology;2022-12-02
5. Linked biaromatic compounds as cardioprotective agents;Archiv der Pharmazie;2021-12-29
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3